Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1975 Jan;11(1):137–141. doi: 10.1128/iai.11.1.137-141.1975

Immune response to hepatitis B surface antigen.

A B Ibrahim, G N Vyas, H A Perkins
PMCID: PMC415036  PMID: 1116872

Abstract

A total of 69 persons were investigated for assessment of cell-mediated and humoral immunity to hepatitis B surface antigen (HBsAg). Three groups, each consisting of 20 normal persons, 20HBsAg carriers, and 20 convalescent hepatitis B patients, were studied for HBsAg, anti-HBs, and leukocyte migration inhibition with purified HBsAg. Sequential sampling if an additional group of nine acute hepatitis B patients defined the cellular and humoral immune response to HBsAg. The antigen was eliminated rapidly by mounting of cell-mediated immune response detectable for a limited period, followed by antibody response in relatively few patients moore than 3 months after clearance of circulating HBsAg.

Full text

PDF
137

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BLUMBERG B. S., ALTER H. J., VISNICH S. A "NEW" ANTIGEN IN LEUKEMIA SERA. JAMA. 1965 Feb 15;191:541–546. doi: 10.1001/jama.1965.03080070025007. [DOI] [PubMed] [Google Scholar]
  2. Cherubin C. E., Szmuness W. Editorial: The emerging epidemiology of hepatitis B antigen. Ann Intern Med. 1973 Nov;79(5):745–746. doi: 10.7326/0003-4819-79-5-745. [DOI] [PubMed] [Google Scholar]
  3. Clot J., Mathieu O., Elharrar S., Robinet-Levy M., Lemaire J. M. Inhibitory effect of Australia-positive sera on in-vitro-stimulated T lymphocytes. Lancet. 1973 Sep 8;2(7828):576–577. doi: 10.1016/s0140-6736(73)92407-0. [DOI] [PubMed] [Google Scholar]
  4. Cossart Y. E. Epidemiology of serum hepatitis. Br Med Bull. 1972 May;28(2):156–162. doi: 10.1093/oxfordjournals.bmb.a070917. [DOI] [PubMed] [Google Scholar]
  5. Dudley F. J., Fox R. A., Sherlock S. Cellular immunity and hepatitis-associated, Australia antigen liver disease. Lancet. 1972 Apr 1;1(7753):723–726. doi: 10.1016/s0140-6736(72)90234-6. [DOI] [PubMed] [Google Scholar]
  6. Dudley F. J., Giustino V., Sherlock S. Cell-mediated immunity in patients positive for hepatitis-associated antigen. Br Med J. 1972 Dec 30;4(5843):754–756. doi: 10.1136/bmj.4.5843.754. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Frei P. C., Erard P., Zinkernagel R. Cell-mediated immunity to hepatitis-associated antigen (HAA) demonstrated by leucocyte migration test during and after acute B hepatitis. Biomedicine. 1973 Sep 20;19(9):379–383. [PubMed] [Google Scholar]
  8. Giustino V., Dudley F. J., Sherlock S. Thymus-dependent lymphocyte function in patients with hepatitis-associated antigen. Lancet. 1972 Oct 21;2(7782):850–853. doi: 10.1016/s0140-6736(72)92212-x. [DOI] [PubMed] [Google Scholar]
  9. Gocke D. J., Howe C. Rapid detection of Australia antigen by counterimmunoelectrophoresis. J Immunol. 1970 Apr;104(4):1031–1034. [PubMed] [Google Scholar]
  10. Ibrahim A. B., Vyas G. N., Prince A. M. Studies on delayed hypersensitivity to hepatitis B antigen in chimpanzees. Clin Exp Immunol. 1974 Jun;17(2):311–318. [PMC free article] [PubMed] [Google Scholar]
  11. Ito K., Nakagawa J., Okimoto Y., Nakano H. Chronic hepatitis--migration inhibition of leukocytes in the presence of Australia antigen. N Engl J Med. 1972 May 4;286(18):1005–1005. doi: 10.1056/nejm197205042861817. [DOI] [PubMed] [Google Scholar]
  12. Krugman S., Giles J. P. Viral hepatitis, type B (MS-2-strain). Further observations on natural history and prevention. N Engl J Med. 1973 Apr 12;288(15):755–760. doi: 10.1056/NEJM197304122881503. [DOI] [PubMed] [Google Scholar]
  13. Laiwah A. A., Chaudhuri A. K., Anderson J. R. Lymphocyte transformation and leucocyte migration-inhibition by Australia antigen. Clin Exp Immunol. 1973 Sep;15(1):27–34. [PMC free article] [PubMed] [Google Scholar]
  14. Ling C. M., Overby L. R. Prevalence of hepatitis B virus antigen as revealed by direct radioimmune assay with 125 I-antibody. J Immunol. 1972 Oct;109(4):834–841. [PubMed] [Google Scholar]
  15. Nielsen J. O., Reinicke V., Dietrichson O., Andersen V., Thomsen M., Andersen E. Immunological studies of Australia antigen carriers with and without liver diseases. Clin Exp Immunol. 1973 Sep;15(1):9–16. [PMC free article] [PubMed] [Google Scholar]
  16. Prince A. M. An antigen detected in the blood during the incubation period of serum hepatitis. Proc Natl Acad Sci U S A. 1968 Jul;60(3):814–821. doi: 10.1073/pnas.60.3.814. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Reed W. D., Mitchell C. G., Eddleston A. L., Lee W. M., Williams R., Zuckerman A. J. Exposure and immunity to hepatitis-B virus in a liver unit. Lancet. 1974 Apr 6;1(7858):581–583. doi: 10.1016/s0140-6736(74)92646-4. [DOI] [PubMed] [Google Scholar]
  18. Robinson W. S., Greenman R. L. DNA polymerase in the core of the human hepatitis B virus candidate. J Virol. 1974 Jun;13(6):1231–1236. doi: 10.1128/jvi.13.6.1231-1236.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Shulman N. R. Hepatitis-associated antigen. Am J Med. 1970 Nov;49:669–692. doi: 10.1016/S0002-9343(70)80133-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Vyas G. N., Shulman N. R. Hemagglutination assay for antigen and antibody associated with viral hepatitis. Science. 1970 Oct 16;170(3955):332–333. doi: 10.1126/science.170.3955.332. [DOI] [PubMed] [Google Scholar]
  21. Vyas G. N., Williams E. W., Klaus G. G., Bond H. E. Hepatitis-associated Australia antigen. Protein, peptides and amine acid composition of purified antigen with its use in determining sensitivity of the hemagglutination test. J Immunol. 1972 Apr;108(4):1114–1118. [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES